ExxonMobil Board of Directors

Article March 1, 2021

In this article

ExxonMobil Board of Directors

Exxon Mobil Corporation Board of Directors

Michael J. Angelakis

Age 56, Director since 2021

Principal occupation: Chairman and Chief Executive Officer of Atairos Group Inc.

Business experience: Mr. Angelakis has served as Chairman and CEO of Atairos since 2015.  He also has served as Senior Advisor to the Executive Management Committee of Comcast Corporation since 2015.  At Comcast, he served as Vice Chairman and Chief Financial Officer from 2011 to 2015, and as Executive Vice President and Chief Financial Officer from 2007 to 2011. He also served as a Managing Director of Providence Equity Partners from 1999 to 2007.

Current public company directorships: Groupon, Inc. (April 2016–Present); TriNet Group, Inc. (February 2017–Present) 

Past public company directorships: Duke Energy Corporation (October 2015–August 2017); Hewlett Packard Enterprise Company (November 2015–April 2020)

Susan K. Avery

Age 71, Director since 2017

Principal occupation: President Emerita of the Woods Hole Oceanographic Institution, a global research organization

Business experience: Dr. Avery served as president and director of the Woods Hole Oceanographic Institution from 2008 to 2015. She served as interim dean of the graduate school and vice chancellor for research, interim provost and executive vice chancellor for academic affairs at the University of Colorado Boulder from 2004 to 2008.

Current public company directorships: None

Past public company directorships: None

Angela F. Braly

Age 59, Director since 2016

Principal occupation: Former Chairman of the Board, President and Chief Executive Officer of WellPoint (now Anthem), a health insurance company

Business experience: Ms. Braly served as chairman of WellPoint from 2010 to 2012; and president and chief executive officer from 2007 to 2012. She served as executive vice president, general counsel and chief public affairs officer of WellPoint from 2005 to 2007, and president and chief executive officer of Blue Cross Blue Shield of Missouri from 2003 to 2005.

Current public company directorships: Brookfield Asset Management Inc. (May 2015–Present); Lowe’s Companies, Inc. (November 2013–Present); The Procter & Gamble Company (December 2009–Present)

Past public company directorships: WellPoint (June 2007–August 2012)

Ursula M. Burns

Age 62, Director since 2012

Principal occupation: Former Chairman of the Board and Chief Executive Officer of VEON Ltd.

Business experience: Ms. Burns served as Chairman of VEON from July 2017 through May 2020, and served as Chief Executive Officer from December 2018 through February 2020. Ms. Burns served as Chairman of Xerox from 2010 to June 2017. She was elected Chief Executive Officer in 2009 and President in 2007, and relinquished these roles in 2016. She also served as Senior Vice President, Corporate Strategic Services; and Senior Vice President and President, Document Systems and Solutions Group, and Business Group Operations, at Xerox.

Current public company directorships: Nestlé S.A.(April 2017–Present); Uber (May 2019–Present)

Past public company directorships: Veon (July 2017–May 2020); Xerox (April 2007–June 2017); American Express (January 2004–May 2018)

Kenneth C. Frazier

Age 66, Director since 2009

Principal occupation: Chairman of the Board and Chief Executive Officer of Merck & Co., Inc.

Business experience: Mr. Frazier was elected chairman and chief executive officer of Merck in 2011, and served as president from 2010 until 2019. He was elected executive vice president and president, Global Human Health, at Merck in 2007; and executive vice president and general counsel in 2006. He served as senior vice president and general counsel at Merck from 1999 to 2006.

Current public company directorships: Merck (January 2011–Present)

Past public company directorships: None

Joseph L. Hooley

Age 63, Director since 2020

Principal occupation: Former Chairman, President and Chief Executive Officer of State Street Corporation 

Business experience: Mr. Hooley served as Chairman of State Street Corporation from 2011 to 2019. He served as Chief Executive Officer from 2010 to 2018 and President from 2008 to 2014.  He previously served as Chief Operating Officer.

Current public company directorships: Aptiv PLC (January 2020–Present)

Past public company directorships: State Street Corporation (October 2010–December 2019)

Steven A. Kandarian

Age 68, Director since 2018

Principal occupation: Former Chairman, President and Chief Executive Officer of MetLife 

Business experience: Mr. Kandarian was elected Chairman of the Board of MetLife in January 2012.   He became President and CEO in May 2011.  He retired from MetLife in April 2019.  Previously, Mr. Kandarian had served as Executive Vice President and Chief Investment Officer.  Before joining MetLife, he was Executive Director of the Pension Benefit Guaranty Corporation.

Current public company directorships: None

Past public company directorships: AECOM (March 2019–February 2021); MetLife (May 2011–April 2019)

Douglas R. Oberhelman

Age 68, Director since 2015

Principal occupation: Former Chairman of the Board and Chief Executive Officer of Caterpillar Inc.

Business experience: Mr. Oberhelman was elected Chairman and Chief Executive Officer of Caterpillar in 2010 and relinquished these roles in 2017 and 2016, respectively. He was elected Group President of Caterpillar in 2002; and Vice President, Engine Products Division in 1998. He also served as Vice President and Chief Financial Officer of Caterpillar from 1995 to 1998.

Current public company directorships: Bombardier (November 2017-Present)

Past public company directorships: Caterpillar (July 2010–March 2017);  Eli Lilly and Company (December 2008–February 2015)

Samuel J. Palmisano

Age 69, Director since 2006

Principal occupation: Former Chairman of the Board, President and Chief Executive Officer, IBM

Business experience: Mr. Palmisano was elected chairman, president, and chief executive officer of IBM in 2003 and relinquished these roles in 2012. Mr. Palmisano also served as president, senior vice president and group executive for IBM’s Enterprise Systems Group, IBM Global Services, and IBM’s Personal Systems Group.

Current public company directorships: None

Past public company directorships: IBM (July 2000–September 2012); American Express (March 2013–May 2019)

Jeffrey W. Ubben

Age 59, Director since 2021

Principal occupation: Founder, Portfolio Manager, and Managing Partner, Inclusive Capital Partners, L.P.

Business experience: Mr. Ubben co-founded Inclusive Capital Partners and has served as Portfolio Manager and Managing Partner since 2020. Mr. Ubben also co-founded and served as Chief Executive Officer of ValueAct Capital Partners, L.P. from 2000 to 2020, and as Chief Investment Officer from 2000 to 2017.  He was a Managing Partner of Blum Capital Partners, L.P. from 1995 to 2000. He also served in various positions including Portfolio Manager and Research Analyst of Fidelity Investments from 1987 to 1995. 

Current public company directorships: AppHarvest, Inc. (May 2019–Present); Enviva Partners, LP (June 2020–Present); Nikola Corporation (September 2019–Present)

Past public company directorships: The AES Corporation (January 2018–March 2021); Twenty-First Century Fox, Inc. (November 2015–April 2018); Willis Towers Watson plc (January 2016–November 2017)

William C. Weldon

Age 72, Director since 2013

Principal occupation: Former Chairman of the Board and Chief Executive Officer, Johnson & Johnson

Business experience: Mr. Weldon was elected chairman and chief executive officer of Johnson & Johnson in 2002, and relinquished the roles of CEO and chairman in 2012. He also served as vice chairman from 2001 to 2002 and as worldwide chairman, Pharmaceuticals Group, from 1998 to 2001.

Current public company directorships: CVS Caremark (March 2013–Present) 

Past public company directorships: JPMorgan Chase (March 2005–April 2019); Chubb (May 2013–January 2016); Johnson & Johnson (February 2001–December 2012)

Darren W. Woods

Age 56, Director since 2016

Principal occupation: Chairman of the Board and Chief Executive Officer, Exxon Mobil Corporation

Business experience: Mr. Woods was elected chairman of the board and chief executive officer of Exxon Mobil Corporation in 2017. He served as president of Exxon Mobil Corporation in 2016, senior vice president from 2014 to 2016, and vice president, and president, ExxonMobil Refining & Supply Company from 2012 to 2014.

Current public company directorships: None

Past public company directorships: Imperial Oil Ltd. (April 2013–July 2014)

Wan Zulkiflee

Age 60, Director since 2021

Principal occupation: Non-Executive Group Chairman of the Board of Directors of Malaysia Airlines and Malaysia Aviation Group

Business experience: Mr. Zulkiflee served as President and Group CEO of Petronas, the national oil and gas company of Malaysia from April 2015 to June 2020. He held various senior management positions, including Chief Operating Officer, in his 37 years at Petronas, prior to becoming President and Group CEO. In July 2020, Mr. Zulkiflee was appointed to his current position at Malaysia Airlines and Malaysia Aviation Group. In September 2020, he was appointed Chairman of DRB HICOM, a diversified business conglomerate.

Current public company directorships: Non-Executive Chairman of DRB-HICOM Berhad (September 2020–Present)

Past public company directorships: None

(Updated as of March 1, 2021)

Powers of the Board

Exxon Mobil Corporation
Board of Directors Resolution Regarding
Powers and Functions Reserved to the Board
November 1, 2016

"RESOLVED, That, in light of the provisions of New Jersey law that  the management of the business and affairs of the Corporation be managed by or under the direction of the Board of Directors and  the provisions of Article IV of the By-Laws, as amended, dealing with the management responsibilities of the officers of the Corporation:

A. the Board reserves the following functions to itself (and, to the extent delegated thereto, to its Committees):

  1. amendment of the By-Laws,
  2. filling vacancies on the Board, designation of nominees for election to the Board by the shareholders, and removing directors from the Board for cause including for any material failure to follow the Standards of Business Conduct, the Corporate Governance Guidelines, or any other obligation owed by directors to the Corporation.
  3. determining whether any director candidate nominated for election under the proxy access or advance notice provisions of the By-Laws meets the requirements of those provisions,
  4. establishment of committees of the Board and appointment of committee members,
  5. election of officers of the Corporation, designation of the chief executive officer of the Corporation and authorization to any officer of the Corporation to appoint assistant officers,
  6. establishment of divisions of the Corporation and appointment of the presidents thereof,
  7. remuneration of the Directors,
  8. setting the date, time and place of shareholder meetings,
  9. submission to shareholders of any action that requires shareholder approval,
  10. approval of the Annual Report and proxy statement,
  11. appointment of independent auditors by the Audit Committee, subject to shareholder ratification and receiving of auditors' reports,
  12. declaration of dividends,
  13. issuance and acquisition of long-term debt or shares of stock, and the fixing of the consideration for treasury shares to be disposed of by the Corporation, except as delegated to the Treasurer as described in B.7 below,
  14. registration and listing of securities and appointment of transfer agents and registrars,
  15. review of summary financial and operating results (quarterly),
  16. adoption of any new major employee benefit plans and programs and approval of any major amendment of an existing major employee benefit plan or program (e.g., Pension Plan and Savings Plan) which might involve substantial cost to the Corporation or significantly alter the scope, nature or degree of benefits,
  17. review of overall policies and objectives for corporate contributions, and approval of contributions budget (annually),
  18. authorization of political contributions and political action committees, except as delegated to officers of the Corporation as described in B.11 below,
  19. adoption of such policies and the taking of such other actions as the Board deems to be in the best interests of the Corporation; and

B. the Board notes that it, or a Board Committee, has heretofore delegated the following specific standing powers to one or more officers of the Corporation and reserves to itself or such Board Committee power to alter any such delegation:

  1. authority to execute documents on behalf of the Corporation,
  2. authority to open and maintain bank accounts,
  3. authority to open and maintain brokerage accounts,
  4. authority to make foreign exchange transactions,
  5. authority to maintain an inventory of Corporation stock in the Treasury,
  6. authority to advance or loan money to, subscribe to equity capital in, guarantee obligations of, and accept deposits from affiliated companies,
  7. authority to enter into tax-exempt financing of the facilities and operations of the Corporation or of its affiliates,
  8. authority to determine whether an indemnity bond shall be required as a condition to the transfer of a share certificate alleged to have been lost, destroyed or wrongfully taken and, if so, the sufficiency thereof,
  9. authority to adopt, terminate, or change employee benefit plans or programs, except major additions or changes to major employee benefit plans or programs,
  10. authority for short term borrowing,
  11. authority to make political contributions in connection with propositions and referenda, to political parties in the United States and to candidates for certain state offices in the United States; and

C. the Board requests that the chief executive officer refer to it (or to a committee of the Board to which it has delegated responsibility) for consideration and, as appropriate, concurrence:

  1. the long term strategy and corporate plan of the Corporation, and significant changes thereto,
  2. investment plans which would involve significant commitments of financial, technological or human resources, or would involve significant risks for the Corporation,
  3. significant sales, transfers, or other dispositions of property or assets,
  4. significant changes in policies of broad application,
  5. major organization changes,
  6. an annual review of political contributions made by Corporation interests in the United States and Canada, and
  7. other matters relating to the Corporation's business which in the judgment of the chief executive officer are of such significance as to merit the Board's consideration.

FURTHER RESOLVED, That the resolution on this subject adopted by the Board on May 28, 2008 be and it hereby is revoked."

Board Committees Overview

The Board appoints Committees to help carry out its duties.  In particular, Board Committees work on key issues in greater detail than would be possible at full Board meetings.  Each Committee reviews the results of its meetings with the full Board. The committee appointments as of March 1, 2021 are listed below.

Click on the Committee title to view that Committee's charter.

Audit Committee

  • Mr. Angelakis
  • Ms. Burns (Chair)
  • Mr. Hooley
  • Mr. Oberhelman
  • Mr. Weldon

Compensation Committee

  • Ms. Braly
  • Mr. Frazier
  • Mr. Kandarian
  • Mr. Palmisano (Chair)

Board Affairs Committee

  • Dr. Avery
  • Mr. Frazier (Chair)
  • Mr. Palmisano
  • Mr. Zulkiflee

Finance Committee

  • Mr. Angelakis
  • Ms. Burns
  • Mr. Hooley
  • Mr. Oberhelman
  • Mr. Ubben
  • Mr. Weldon
  • Mr. Woods (Chair)

Public Issues and Contributions Committee

  • Dr. Avery
  • Ms. Braly (Chair)
  • Mr. Kandarian
  • Mr. Ubben
  • Mr. Zulkiflee

Executive Committee

  • Ms. Burns
  • Mr. Frazier
  • Mr. Palmisano
  • Mr. Weldon
  • Mr. Woods (Chair)

Other directors serve as alternate members of the Executive Committee on a rotational basis.

 

Related content

Code of ethics

Performing with the highest ethical standards of business conduct is a key competitive strength — critical to maintaining our global license to operate.

Corporate governance Article

Corporate governance guidelines and additional policies

Corporate governance Article

Audit Committee Pre-Approval Policy and Procedure Memorandum for Services Obtained from the Independent Auditor

Corporate governance Article

Policy Statement on Poison Pills

ExxonMobil does not have a 'poison pill' or shareholder rights plan and the Board considers it unlikely that such a plan would be considered in the future.

Corporate governance Article

Policy Statement on Option Repricing

Corporate governance Article

Procedures for Shareholders and Other Interested Parties to Communicate to the Non-Employee Directors

Corporate governance Article